RESEARCH PAPER
No effect of 7-nitroindazole on the anticonvulsant action of vigabatrin and oxcarbazepine in pentylenetetrazole-induced seizures in mice
 
More details
Hide details
1
Department of Pathophysiology, Medical University, Lublin, Poland
2
Department of Physiopathology, Institute of Agricultural Medicine, Lublin, Poland
3
First Department of Internal Medicine with Dialysis Station, County Hospital, Starachowice, Poland
 
JPCCR 2008;2(2):137–140
KEYWORDS:
ABSTRACT:
The aim of this study was to determine the effect of 7-nitroindazole (7-NI – a preferential neuronal nitric oxide synthase inhibitor) on the protective action of oxcarbazepine (OXC) and vigabatrin (VGB) – two newer antiepileptic drugs (AEDs) against pentylenetetrazole (PTZ)-induced seizures in mice. The clonic seizure activity in mice was evoked by subcutaneous injection of PTZ (100 mg/kg) and defined as clonus of the whole body lasting over 3 s with an accompanying loss of righting reflex in mice. The protective action of OXC and VGB against PTZ-induced clonic seizures was expressed as their median effective doses (ED50 values) suppressing clonic seizures in 50% of animals tested. The acute adverse-effect potentials of OXC and VGB in combination with 7-NI were evaluated in the chimney test (motor coordination) in mice. Results indicate that 7-NI administered intraperitoneally (50 mg/kg) did not significantly affect the anticonvulsant action of OXC or VGB against PTZ-induced clonic C. The ED50 values for OXC administered alone and in combination with 7-NI were 20.9 and 24.8 mg/kg. Similarly, the ED50 values for VGB administered alone and in combination with 7-NI were 595 and 622 mg/kg, respectively. Moreover, the examined combinations of 7-NI (50 mg/kg) with OXC (24.8 mg/kg) and VGB (622 mg/kg) did not aff ect motor coordination in the chimney test. In conclusion, 7-NI had no significant impact on the anticonvulsant activity of OXC and VGB in the mouse PTZ-induced seizure model, and did not affect motor coordination in animals subjected to the chimney test.
CORRESPONDING AUTHOR:
Jarogniew J. Łuszczki   
Department of Pathophysiology, Medical University, Jaczewskiego 8, 20-090 Lublin, Poland.
 
REFERENCES (29):
1. Iadecola C: Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997, 20, 132-139.
2. Moncada S, Higgs EA: Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995, 9, 1319-1330.
3. Montecot C, Borredon J, Seylaz J, Pinard E: Nitric oxide of neuronal origin is involved in cerebral blood fl ow increase during seizures induced by kainate. J Cereb Blood Flow Metab 1997, 17, 94-99.
4. Szabo C: Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res Bull 1996, 41, 131-141.
5. Baran L, Siwanowicz J, Przegaliński E: Eff ect of nitric oxide synthase inhibitors and molsidomine on the anticonvulsant activity of some antiepileptic drugs. Pol J Pharmacol 1997, 49, 363-368.
6. De Sarro G, Gareri P, Falconi U, De Sarro A: 7-Nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Eur J Pharmacol 2000, 394, 275-288.
7. Łuszczki JJ, Czuczwar M, Gawlik P, Sawiniec-Poźniak G, Czuczwar K, Czuczwar SJ: 7-Nitroindazole potentiates the anticonvulsant action of some second-generation antiepileptic drugs in the mouse maximal electroshock-induced seizure model. J Neural Transm 2006, 113, 1157- 1168.
8. Łuszczki JJ, Sacharuk A, Wojciechowska A, Andres MM, Dudra- Jastrzębska M, Mohamed M, Sawicka KM, Kozińska J, Czuczwar SJ: 7-Nitroindazole enhances dose-dependently the anticonvulsant activities of conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Pharmacol Rep 2006, 58, 660- 671.
9. Smith SE, Man CM, Yip PK, Tang E, Chapman AG, Meldrum BS: Anticonvulsant eff ects of 7-nitroindazole in rodents with refl ex epilepsy may result from L-arginine accumulation or a reduction in nitric oxide or L-citrulline formation. Br J Pharmacol 1996, 119, 165-173.
10. Tutka P, Łuszczki J, Kleinrok Z, Arent K, Wielosz M: Molsidomine enhances the protective activity of valproate against pentylenetetrazoleinduced seizures in mice. J Neural Transm 2002, 109, 455-466.
11. Han D, Yamada K, Senzaki K, Xiong H, Nawa H, Nabeshima T: Involvement of nitric oxide in pentylenetetrazole-induced kindling in rats. J Neurochem 2000, 74, 792-798.
12. Borowicz KK, Łuszczki J, Kleinrok Z, Czuczwar SJ: 7-Nitroindazole, a nitric oxide synthase inhibitor, enhances the anticonvulsive action of ethosuximide and clonazepam against pentylenetetrazol-induced convulsions. J Neural Transm 2000, 107, 1117-1126
13. Łuszczki JJ, Szadkowski M, Dudra-Jastrzębska M, Czernecki R, Filip D, Misiuta-Krzesińska M, Barcicka-Kłosowska B, Zwoliński J: 7- Nitroindazole does not aff ect the anti-convulsant action of gabapentin and tiagabine in pentylenetetrazole-induced seizures in mice. JPCCR 2007, 1, 150-154.
14. Łuszczki JJ, Zadrożniak A, Barcicka-Kłosowska B, Bednarski J, Misiuta-Krzesińska M, Filip D, Zwoliński J, Czernecki R: Infl uence of 7-nitroindazole and NG-nitro-L-arginine on the anticonvulsant activity of loreclezole in maximal electroshock-induced seizures in mice. JPCCR 2007, 1, 146-149.
15. Borowicz KK, Kleinrok Z, Czuczwar SJ: Infl uence of 7-nitroindazole on the anticonvulsive action of conventional antiepileptic drugs. Eur J Pharmacol 1997, 331, 127-132.
16. Rajasekaran K, Jayakumar R, Venkatachalam K: Increased neuronal nitric oxide synthase (nNOS) activity triggers picrotoxin-induced seizures in rats and evidence for participation of nNOS mechanism in the action of antiepileptic drugs. Brain Res 2003, 979, 85-97.
17. Loscher W, Honack D, Fassbender CP, Nolting B: The role of technical, biological and pharmacological factors in the laboratory evaluation anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res 1991, 8, 171-189.
18. Loscher W, Nolting B: The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices. Epilepsy Res 1991, 9, 1-10.
19. Łuszczki JJ, Szadkowski M, Czuczwar SJ: Eff ect of NG-nitro-L-arginine on the anticonvulsive action of four second-generation antiepileptic drugs in pentetrazole-induced clonic seizures in mice. Pharmacol Rep 2007, 59, 467-473.
20. Litchfi eld JT, Wilcoxon F: A simplifi ed method of evaluating dose-eff ect experiments. J Pharmacol Exp Ther 1949, 96, 99-113.
21. Łuszczki JJ, Czuczwar SJ: Isobolographic profi le of interactions between tiagabine and gabapentin: a preclinical study. Naunyn Schmiedebergs Arch Pharmacol 2004, 369, 434-446.
22. Łuszczki JJ, Czuczwar SJ: Isobolographic characterisation of interactions among selected newer antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model. Naunyn Schmiedebergs Arch Pharmacol 2005, 372, 41-54.
23. Łuszczki JJ, Wojcik-Ćwikła J, Andres MM, Czuczwar SJ: Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis. Neuropsychopharmacology 2005, 30, 958-973.
24. Świąder M, Łuszczki J, Wielosz M, Czuczwar SJ: Infl uence of vigabatrin, a novel antiepileptic drug, on the anticonvulsant activity of conventional antiepileptics in pentetrazole-induced seizures in mice. Pol J Pharmacol 2003, 55, 363-370.
25. Łuszczki JJ: Isobolographic analysis of interaction between oxcarbazepine and valproate in pentylenetetrazole-induced seizures in mice. JPCCR 2008, 2, 40-45.
26. Boissier JR, Tardy J, Diverres JC: Une nouvelle methode simple pour explorer l’action ‘tranquilisante’: le test de la cheminee. Med Exp (Basel) 1960, 3, 81-84.
27. Łuszczki JJ, Czuczwar M, Gawlik P, Sawiniec-Poźniak G, Czuczwar K, Sawicka KM, Dudra-Jastrzębska M, Czuczwar SJ: Infl uence of NGnitro- L-arginine on the anticonvulsant and acute adverse eff ects of some newer antiepileptic drugs in the maximal electroshock-induced seizures and chimney test in mice. Pharmacol Rep 2006, 58, 955-960.
28. Czuczwar SJ, Tutka P, Klonowski P, Kleinrok Z: N(G)-nitro-Larginine impairs the anticonvulsive action of ethosuximide against pentylenetetrazol. Eur J Pharmacol 1999, 366, 137-142.
29. Łuszczki JJ, Czuczwar SJ: Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31, 529- 538.
eISSN:1898-7516
ISSN:1898-2395